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Quality of life' may play a key role in determining outcomes of major 
surgery, according to research conducted by School of Medicine 
scientists C. David Jenkins, Ph.D., and Babette-Ann Stanton, Ph.D. See 
story on page 3. 
A University Hospital patient is prepared for cardiac catfieterization, a procedure tliat resem-
bles that of transluminal angioplasty. (Photo by Bradford F. Herzog) 
Angioplasty works — but how and 
why? BUSM study looks for answers 
One of the newest and most promis-
ing innovations in the treatment of 
coronary artery disease in humans is 
transluminal angioplasty, a technique 
in which a balloon-tipped catheter is 
used to dilate a partially blocked 
segment of a coronary artery, creat-
ing a wider opening for the passage 
of blood to the heart. 
Animal studies being conducted at 
Boston University School of Medicine 
under the leadership of Assistant 
Professor David P. Faxon, M.D., aim 
to elucidate how and why the proce-
dure works, and to make it even 
more effective and broaden its use 
for humans. 
Transluminal angioplasty has been 
successfully used as an alternative to 
coronary bypass surgery for some 
1,800 carefully selected patients 
worldwide. It also has been success-
fully applied to atherosclerotic nar-
rowings in the peripheral blood ves-
sels of the legs, and in the renal and 
continued on page 5 
Alcohol's effect 
on the brain is 
focus of BUSM 
research team 
Doctor: Do you remember about 
two minutes ago I told you how long 
you've been in this hospital and 
what hospital you were in? 
Patient: No, I don't remember. 
Doctor: Do you remember the 
house you first lived in as a child? 
Patient: Fourth house up from the 
corner. It was a gray one - four or 
five tenements. It was one of the 
biggest houses on the street. 
The above is a dialogue between a 
Boston University School of Medicine 
researcher and an alcoholic patient 
who has Korsakoff's syndrome, a 
complex psychological and neurolog-
ical disorder generally characterized 
by a particular type of amnesia — a 
loss of memory for very recent 
events, but a fairly good memory for 
events of early childhood and before 
the onset of the disease. 
Named after the Russian 
neurologist who first described the 
disorder in the late 1800s, the syn-
drome often is associated with long-
term chronic alcoholism accom-
panied by malnutrition. It can, how-
ever, accompany serious disorders 
involving the intestinal tract and often 
is attributed to damage of structures 
deep inside the brain, such as the 
thalamus and the hypothalamus, ac-
cording to Marlene Oscar Berman, 
Ph.D. An associate professor of 
continued on page 2 
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Alcohol's effect... 
continued from page 1 
neurology (neuropsychology) at the 
School, Berman has done a great 
deal of research on Korsakoff pa-
tients in her 11-year study on the ef-
fects of long-term chronic alcoholism 
on the brain. 
"Though Korsakoff's syndrome af-
fects only a small percentage of al-
coholics, its effects are profound and 
offer important clues to how the brain 
works. I am interested in how the 
brain controls behavior, and I want to 
get a good handle on what deficien-
cies occur in the brain as a result of 
chronic alcohol abuse," said Berman, 
who does most of her research at 
the Boston Veterans Administration 
Medical Center, a principal teaching 
facility of BUSM. "I hope that this re-
search will aid in the understanding 
of such disorders as amnesia and be 
useful in the diagnosis and treatment 
of persons who have abused alco-
hol," she added. 
Berman, who also directs the Lab-
oratory of Neuropsychology in 
BUSM's Department of Biobehavorial 
Sciences of the Division of 
Psychiatry, this year received grants 
totaling nearly $500,000 to support 
her continuing research. The grants 
were from the National Institute for 
Alcohol Abuse and Alcoholism of the 
U.S. Department of Health and 
Human Services and from the Veter-
ans Administration. 
She is affiliated with BUMC's 
Aphasia Research Center headed by 
Harold Goodglass, Ph.D., a professor 
of neurology (neuropsychology). 
Others conducting alcohol research 
in the Aphasia Center include Nelson 
Butters, Ph.D., a professor of neurol-
ogy, and Laird S. Cermak, Ph.D., an 
associate professor of neurology. 
Berman is assisted in her research 
by psychology technician Robert 
Bonner. 
It is generally accepted that 
chronic alcohol abuse can lead to cir-
rhosis of the liver and damage the 
circulatory, muscular, endocrine and 
nervous systems, but relatively little 
is known about how brain damage 
caused by alcohol affects behavior. 
Berman has found that patients 
with Korsakoff's syndrome, though 
they might have normal or above-
normal IQs, have subtle deficiencies 
in attention, perception and motiva-
tion processes that are thought to 
contribute to the patients' memory 
loss. 
To determine whether or not 
Korsakoff patients had perception or 
attention difficulties, the researchers 
used a machine called a tachisto-
scope (t-scope) to measure the 
amount of time it took alcoholic 
Korsakoff patients to analyze incom-
ing visual information. The research-
ers measured the amount of time a 
word or figure was shown on the 
screen of the t-scope before the pa-
tients could identify what they had 
seen. They found that Korsakoff pa-
tients needed nearly three times the 
amount of viewing time as normal 
subjects and alcoholic patients with 
no clinical signs of Korsakoff's syn-
drome. 
In other tests, Berman found that: 
• It took Korsakoff patients twice as 
long to categorize and convert infor-
Marlene Oscar Berman, Ph. D., at left, 
discusses her research. Cross-
sectional diagram of human brain, 
above, shows the thalamus and 
hypothalamus. Damage to these struc-
tures is believed to be related to alco-
holic Korsakoff's syndrome. (Photo by 
Bradford P. Herzog; diagram by 
BVAMC Medical Media) 
mation about a visual stimulus no 
longer present on the t-scope into 
the short-term memory than it did 
normal control subjects. "It became 
clear that Korsakoff patients do not 
process incoming visual information 
as efficiently as control subjects. This 
was our first evidence that the mem-
ory impairment of Korsakoff patients 
might be confounded with other defi-
cits, in this case a limited information 
processing capacity," Berman said. 
• Korsakoff patients responded pre-
maturely to incoming information, 
particularly when required to withhold 
a response for a period of time. They 
also tended to repeatedly use incor-
rect strategies in problem-solving, 
even after they had been told they 
were wrong. "Similar tests run on 
nonalcoholic brain-damaged individ-
uals in the control group showed that 
these patients were able to formulate 
and use hypotheses normally, 
suggesting that brain damage alone 
is not responsible for the pattern of 
results obtained in those with alco-
holic Korsakoff's syndrome," Berman 
explained. 
• In tests of motivational skills, the 
alcoholic Korsakoff patient cooper-
ated fully and wanted to participate, 
but exhibited an abnormally low sen-
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Unique study aims to document factors 
affecting recovery from heart surgery 
sitivity to existing reward contingen-
cies. "Abnormalities in sensitivity to 
available rewards can have direct 
bearing on the ability to learn new 
material. If someone is only dimly 
aware of the relevance of a particular 
item, or some piece of information is 
seemingly unimportant, that item or 
information may never be learned," 
Berman said. "Like deficits in percep-
tual processing or attention, defects 
in learning may appear as problems 
of memory. 
"The functions that are disrupted in 
alcoholic Korsakoff's disease are 
themselves very much intertwined," 
she added. "Memory depends upon 
what has been learned, and vice 
versa. Learning and memory depend 
upon attention, motivation and the 
amount of information that can be 
processed. A minimal level of arousal 
is needed to process information. 
Arousal and attention are heightened 
by increases in perceptual proces-
sing and motivation. 
"In the years since Korsakoff first 
described the disease, much has 
been added to our facts about 
organically-based memory disorders, 
but the amnesias are still far from 
being fully understood. Perhaps after 
another decade of research the prob-
lem will be solved — but not forgot-
ten," she said. 
— Marjorie H. Dwyer 
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Candidates for heart surgery who 
are likely to have successful out-
comes and those who might need 
extra services to improve their 
chances for full recovery are ex-
pected to become more easily identi-
fiable as a result of research being 
conducted at Boston University 
School of Medicine. 
For six years, 0. David Jenkins, 
Ph.D., a professor of psychiatry, and 
Babette-Ann Stanton, Ph.D., an as-
sistant research professor of 
medicine (health-care research) at 
BUSM, have been conducting 
studies of persons who have under-
gone coronary artery bypass graft 
and cardiac valve replacement to de-
termine what such factors as attitude, 
emotions, or social relations have on 
the course of recovery and rehabilita-
tion following surgery. 
"This new knowledge may lead to 
better patient selection and more 
complete postoperative services," 
Jenkins said of the study, which is 
funded by the National Heart, Lung 
and Blood Institute. 
The research effort is believed to 
be one of the first of its type to eval-
uate the medical significance of what 
some call the "quality of life," or the 
sum total of a person's health and 
well-being. 
"With few exceptions, previous re-
searchers have limited their evalua-
tions to morbidity and mortality rates 
and other medical outcomes follow-
ing heart surgery, or to future risks of 
severe complications," Stanton said. 
"Other studies have investigated re-
duction of anginal pain after surgery 
or have followed patients to see if 
they returned to work," she con-
tinued. 
"Although these are all important 
components of the quality of life," 
Jenkins added, "they do not provide 
an adequate evaluation for many 
persons who undergo heart surgery 
after their retirement or for those pa-
tients who did not have serious an-
gina pain before surgery. 
"The goal of medical care should 
be to preserve, restore and extend 
the quality of life," he continued. 
"The evaluation of the degree to 
which a health-care technique or 
program achieves that goal calls for 
the application to patients of valid, re-
liable and convenient measures of 
the quality of life concept," he said. 
"It is urgent that medical and sur-
gical intervention be evaluated from 
a broad perspective of total human 
well-being, and to this end we have 
assembled and are using a com-
prehensive array of scales in an at-
tempt to move toward a reliable 
measurement of a complete spec-
trum of essential components of the 
concept of the quality of life," Jenkins 
explained. 
The investigators developed an ex-
tensive questionnaire containing 
1,000 queries relating to such areas 
as health (rehospitalization, degree 
of disability, new medical diagnoses 
implying risk), emotional states (anx-
iety, depression, fatigue, hostility, 
vigor, hope), self-esteem, satisfaction 
with one's career, family life, stan-
dard of living, and educational level. 
The study also includes questions 
pertaining to such daily activities and 
role functions as physical activity 
levels, family and marital roles, 
recreational activities, occupational 
roles, retirement activities and social 
participation. 
Social participation is an important 
aspect of one's quality of life, Jenkins 
noted. For example, he said, physical 
disability can prevent the mobility 
necessary to go out and visit friends. 
Depression and hostility may sepa-
rate a person from others, while the 
individual who returns to work can 
maintain social contacts. "For these 
reasons," he said, "we judged it im-
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Investigators C. David Jenkins, Ph.D., and Babette-Ann Stanton, Ph.D., who are studying heart 
surgery outcomes, discuss data in their Medical Center office. (Photo by Bradford F. Herzog) 
portant to obtain direct measures of 
the quantity and quality of interper-
sonal interactions." Questions about 
income levels also were included in 
the study. 
"The design of the study is 
unique," Stanton explained. "It in-
volves the collection of baseline data 
in the days immediately preceding 
heart surgery, a brief interview in the 
hospital nine days after surgery, and 
extensive follow-up — both through 
interviews and a questionnaire — at 
6, 12, 18 and 24 months following 
surgery. This is the greatest number 
of follow-up variables ever studied in 
a project of this type," she said. 
Currently 520 persons are enrolled 
in the study and postoperative infor-
mation has been compiled on ap-
proximately 334 participants. The 
four study sites include Boston Uni-
versity Medical Center, Beth Israel 
Hospital in Boston, the University of 
Massachusetts Medical Center in 
Worcester, Mass., and Albert Ein-
stein Medical Center in New York 
City. 
The baseline interview, conducted 
one or two days prior to surgery, 
contains several standard scales 
measuring emotional states. The in-
vestigators found that the anxiety 
levels in their sample were lower 
than expected, perhaps in part be-
cause 27 percent were prescribed 
preoperative tranquilizers. Patients 
anticipating a valve replacement ex-
perienced slightly less depression 
than bypass patients, but the other 
mood scales did not show any con-
sistent patterns of differences. 
Valve patients, in general, were 
more hopeful about their life situa-
tions following surgery than were 
bypass patients, but there was little 
difference between the groups in a 
measure of current life satisfaction. 
When all patients were asked about 
their expectations of the impact of 
surgery on their future quality of life, 
more than half were extremely op-
timistic. Fewer than 5 percent of the 
patients were unsure or pessimistic 
about their quality of life after 
surgery. "This attests to the excellent 
preparation surgeons, their staffs and 
nurses gave these patients prior to 
surgery," Stanton said. 
"We believe that profiles of the 
multiple dimensions of quality of life 
can provide insights into which com-
ponents of a comprehensive care 
system need strengthening," Stanton 
said. "Such data also could provide 
the basis for special forms of 
supplementation to the process of 
patient education, such as more em-
phasis on return-to-work counseling 
for heart-surgery patients. 
"If there are common factors be-
hind the great individual differences 
in profile of recovery," she con-
cluded, "such data could be used to 
improve patient selection as well as 
for early identification of persons with 
a high probability of difficulty with a 
specific aspect of recovery, such as 
proneness to depression or marital 
conflict." 
Working with Jenkins and Stanton 
on the study are Michael Klein, M.D., 
an associate professor of medicine at 
the School of Medicine, and Judith A. 
Savageau, M.P.H., a research asso-
ciate in psychiatry. 
Robert L. Berger, M.D., a profes-
sor of surgery at the School of 
Medicine and chief of cardiothoracic 
surgery at University Hospital, and 
John R. McCormick, M.D., an assis-
tant professor of surgery, are col-
laborators for the project. 
— Susan B. Saperstein 
Suggested Further Readings 
1. Zyzanski, Stephen J. et al: Medical and 
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heart surgery. J Psychosomatic Res. 23: 
213-221, 1981. 
2. Heller, S.S. et al: Psychological outcome fol-
lowing open-heart surgery. Arch Int Med. 
734 :908 ,1974. 
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Angioplasty... 
continued from page 1 
even the cerebral arteries of patients. 
The procedure's brief history 
began in the early 1960s, when a 
radiologist named Charles Dotter, 
using a catheter to explore arterial 
narrowings, got the idea of using a 
slightly larger catheter not only to 
probe but to widen the narrowed 
vessels. He applied the technique 
successfully in the iliac arteries in the 
legs of patients with atherosclerosis, 
or hardening of the arteries. 
Some 10 years later, a German 
physician named Zeitler adapted the 
procedure, again for use in leg ar-
teries. But it was a student of Zeitler, 
a young German named Andreas 
Gruntzig, who added the ingenious 
refinement that gives the procedure 
its importance today as a therapeutic 
tool. Gruntzig added to the catheter a 
small plastic balloon that could be 
guided to an area of arterial narrow-
ing and there inflated with fluid to a 
predetermined size to widen the arte-
rial opening. Having used the tech-
nique with great success on arteries 
of the legs, Gruntzig went on to de-
vise a very tiny balloon for use in the 
coronary arteries, and used it suc-
cessfully on his first heart patient in 
September 1977. 
News of Gruntzig's experiment 
caused great excitement in the world 
of cardiology. Preliminary experi-
ments in this country prompted the 
National Institutes of Health to set up 
a data registry to follow up on all pa-
tients treated by the procedure. 
Faxon was among the car-
diologists attending the 1977 Miami 
meeting where Gruntzig first de-
scribed the procedure. Two years 
later, Faxon, who also is the director 
of the Cardiac Catheterization Labo-
ratory at University Hospital, went to 
Zurich to learn the technique from 
Gruntzig himself. Since then, he and 
his UH associates have treated 26 
patients with the technique, with re-
sults Faxon describes as "very 
good." 
Approximately 70 percent of the 
1,800 angioplasties that have been 
done worldwide have successfuly 
decreased the arterial narrowing by 
20 percent or more. About 15 to 20 
percent of these patients, however, 
experienced a return of the stenosis, 
or narrowing, within six months to a 
year. (Interestingly, these outcomes 
are similar to those of coronary 
bypass surgery, in which a compara-
ble percentage of patients experi-
ence clogging of the new bypass 
graft within six months to a year, 
Faxon noted.) Why this happens, 
and what factors determine who will 
experience restenosis (return of the 
narrowing), are among the many 
questions challenging the research-
ers. 
"After we had done the angioplasty 
procedure on patients here and read 
the literature, it became immediately 
obvious that no one understands 
how it works or why it enlarges the 
internal size of the arteries," Faxon 
explained. 
He formed a research team that 
set out with three primary goals: to 
develop an animal model suitable for 
angioplasty; to find out how the pro-
cedure works; and to try to learn 
what factors might prevent re-
narrowing. The project is supported 
by a three-year grant from the Na-
tional Heart, Lung and Blood Insti-
tute. 
The research was done in rabbits, 
whose iliac arteries are similar in size 
to human coronary arteries. Rabbits 
also can be induced to develop sig-
nificant arterial narrowing in as little 
as six to 10 weeks. 
The rabbits were divided into two 
main groups in which different kinds 
of atherosclerotic lesions were to be 
induced since atherosclerosis begins 
with an injury to the artery wall. Rab-
bits in Group I were subjected to 
de-endotheliazation — the gentle 
scraping away of the inner lining of 
cells at a particular point in the iliac 
artery. The animals then were placed 
on an extremely high cholesterol diet. 
The Group II animals had their le-
sions induced by surgically placing a 
small polyethylene catheter in the ar-
tery and leaving it there for eight 
weeks. These animals were then 
subdivided into two groups: the first 
was fed a high-cholesterol diet and 
the second, a normal diet of rabbit 
food. 
After eight weeks, the rabbits' ar-
teries were examined by angiog-
raphy; most were found to have sig-
nificant narrowing. Angioplasty then 
was performed on all the animals, 
and the next day they were sacrificed 
so that their tissues could be 
examined under the microscope. 
Photo on left shows rabbit artery that has undergone the transluminal angioplasty procedure. 
Note that the vessel opening has been enlarged by the procedure. Photo on right shows the 
renarrowing of a rabbit artery that has undergone angioplasty four weeks following the proce-
dure. (Mallory Institute of Pathology photos) 
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"We found that the type of lesion 
determined what you found (after 
angioplasty)," Faxon reported. Group 
I animals had developed concentric, 
fatty, so-called foam-cell-type lesions. 
After angioplasty, four of the six rab-
bits in this group were found to have 
suffered a partial rupture of the ves-
sel wall, extending through the intima 
(the inner layer of cells, or en-
dothelium) and in some cases part-
way into the media, the vessel's sec-
ond, muscular layer of cells. 
Group II rabbits tended to form ec-
centric lesions — that is, plaques 
that built up on only one side of the 
artery; these lesions tended to be 
harder and more fibrous than those 
in Group I. In these animals, angio-
plasty tended to stretch the normal 
portion of the vessel wall, rather than 
the more resistant lesion, causing an 
aneurism. 
In another study of the long-term 
results of transluminal angioplasty, 
the researchers found that the rab-
bits on high-cholesterol diets tended 
to redevelop atherosclerosis at the 
site of the angioplasty more rapidly 
than in other parts of the vessel. Six 
out of nine animals had restenosis of 
more than 20 percent. Furthermore, 
the animals that showed the greatest 
improvement from angioplasty were 
the most likely to develop restenosis. 
"We don't know why this should be 
so," Faxon said. "Maybe it has to do 
with the amount of damage you do 
(to the artery) with the initial angio-
plasty." 
Faxon's six-member research team 
includes Christian Haudenschild, 
M.D., an associate professor of 
pathology at BUSM and a pathologist 
at the Mallory Institute of Pathology, 
who is an expert in animal 
atherosclerosis. 
In the next phase of its research, 
the team will attempt to alter the re-
stenosis rate by giving the rabbits 
blood-thinning drugs and a calcium-
blocking agent. Later, the research-
ers will examine the effects of 
variations in the angioplasty tech-
nique. Currently, a patient receives 
angioplasty once, in a procedure that 
usually involves inflating the balloon 
three times, to a pressure five times 
normal atmospheric pressure, Faxon 
explained. 
Although only about 10 percent of 
those who are candidates for coro-
nary bypass surgery currently qualify 
for angioplasty because of guidelines 
set up by NIH, Faxon predicts that 
improvements in equipment coupled 
with increased familiarity with the 
procedure among physicians causing 
it to be viewed as no longer experi-
mental will mean a significant in-
crease in the percentage of patients 
qualifying for angioplasty in the not-
too-distant future. 
Despite Faxon's findings, which 
suggest that transluminal angioplasty 
not only fails to prevent renarrowing 
of the arteries, but may actually en-
courage it, he is convinced of the 
technique's long-range value. "Our 
results only tell us that it's not per-
fect . . . They also tell us that some 
of the animals, like most of the 
people, do very well. 
"In the animal, we see in a four-
week period what might take 10 
years to develop in a human being. 
But if we can determine what makes 
the procedure more successful and 
apply that to humans, then maybe 
the 10 years (before restenosis oc-
curs) can be extended to 20. If you 
have a procedure that can let you go 
20 years without heart surgery, that's 
enormously important." 
— Lorraine W. Lovigiio 
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